Diabetes Mellitus: Target Enzymes and Drugs highlights the importance of different targets in lead drug discovery and the importance of the synthesis of lead analogues. The book discusses the role of target enzymes, receptors, and related drugs in diabetes mellitus that are necessary for research on improving solutions for diabetes care. This unique resource provides information about all enzymes or receptors involved in diabetes pathophysiology to help describe target enzymes and potent antidiabetic drugs to improve patient care.
This type of research is needed for the understanding of the effects of drugs in order to improve future treatments and care of patients with diabetes.
1. Chapter 1. Introduction to diabetes mellitus - p. 1 2. Chapter 2. Dipeptidyl peptidase-4 enzyme in diabetes mellitus - p. 21 3. Chapter 3. PPARγ (peroxisome proliferator-activated receptor gamma) receptor in diabetes mellitus - p. 43 4. Chapter 4. Alpha-glucosidase in diabetes mellitus - p. 63 5. Chapter 5. Sodium-glucose cotransporter-2 (SGLT2) inhibitors (gliflozins) in diabetes mellitus: mechanisms and therapeutic insights - p. 79 6. Chapter 6. Insulin agonist in diabetes mellitus - p. 109 7. Chapter 7. Glucagon-like-peptide-1 receptor agonists in diabetes mellitus - p. 121 8. Chapter 8. Amylin in diabetes mellitus - p. 145 9. Chapter 9. Miscellaneous drug combinations in diabetes mellitus - p. 159 10. Chapter 10. Antidiabetic drugs from natural sources - p. 177 11. Chapter 11. Future challenges in targeted drugs for diabetes mellitus - p. 205 12. Chapter 12. Existing pharmacological challenges and the need for improved therapies - p. 225 13. Chapter 13. Data analysis in diabetes and the role of technology in diabetes management - p. 239 14. Index - p. 273
Diabetes Mellitus: Target Enzymes and Drugs highlights the importance of different targets in lead drug discovery and the importance of the synthesis of lead analogues. The book discusses the role of target enzymes, receptors, and related drugs in diabetes mellitus that are necessary for research on improving solutions for diabetes care. This unique resource provides information about all enzymes or receptors involved in diabetes pathophysiology to help describe target enzymes and potent antidiabetic drugs to improve patient care.
This type of research is needed for the understanding of the effects of drugs in order to improve future treatments and care of patients with diabetes.
1. Chapter 1. Introduction to diabetes mellitus - p. 1 2. Chapter 2. Dipeptidyl peptidase-4 enzyme in diabetes mellitus - p. 21 3. Chapter 3. PPARγ (peroxisome proliferator-activated receptor gamma) receptor in diabetes mellitus - p. 43 4. Chapter 4. Alpha-glucosidase in diabetes mellitus - p. 63 5. Chapter 5. Sodium-glucose cotransporter-2 (SGLT2) inhibitors (gliflozins) in diabetes mellitus: mechanisms and therapeutic insights - p. 79 6. Chapter 6. Insulin agonist in diabetes mellitus - p. 109 7. Chapter 7. Glucagon-like-peptide-1 receptor agonists in diabetes mellitus - p. 121 8. Chapter 8. Amylin in diabetes mellitus - p. 145 9. Chapter 9. Miscellaneous drug combinations in diabetes mellitus - p. 159 10. Chapter 10. Antidiabetic drugs from natural sources - p. 177 11. Chapter 11. Future challenges in targeted drugs for diabetes mellitus - p. 205 12. Chapter 12. Existing pharmacological challenges and the need for improved therapies - p. 225 13. Chapter 13. Data analysis in diabetes and the role of technology in diabetes management - p. 239 14. Index - p. 273
